{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:11:26Z","timestamp":1758417086409,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.lfs.2022.120380","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:03:38Z","timestamp":1644235418000},"page":"120380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hydrazonoyl chlorides possess promising antitumor properties"],"prefix":"10.1016","volume":"295","author":[{"given":"Mohamed A.M.","family":"El Gendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamdy","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feridoun","family":"Karimi-Busheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesfin","family":"Fanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shorouk","family":"Morsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merna","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Hemid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdel Azeiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Fared","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weinfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.lfs.2022.120380_bb0005","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.ejca.2014.08.017","article-title":"Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: is efficacy an impact of toxicity?","volume":"50","author":"Soveri","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2022.120380_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them","volume":"149","author":"Koch","year":"2021","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.lfs.2022.120380_bb0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jare.2016.09.001","article-title":"A review on bis-hydrazonoyl halides: recent advances in their synthesis and their diverse synthetic applications leading to bis-heterocycles of biological interest","volume":"7","author":"Shawali","year":"2016","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120380_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ardp.201100212","article-title":"Hydrazonoyl halides as precursors for new fused heterocycles of 5alpha-reductase inhibitors","volume":"345","author":"Farghaly","year":"2012","journal-title":"Arch. Pharm."},{"issue":"5","key":"10.1016\/j.lfs.2022.120380_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrd3374","article-title":"Harnessing synthetic lethal interactions in anticancer drug discovery","volume":"10","author":"Chan","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.lfs.2022.120380_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/13543776.2019.1669562","article-title":"An update on PTEN modulators - a patent review","volume":"29","author":"Boosani","year":"2019","journal-title":"Expert Opin.Ther.Patents"},{"issue":"10","key":"10.1016\/j.lfs.2022.120380_bb0045","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/1535-7163.MCT-12-1093","article-title":"Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase\/phosphatase","volume":"12","author":"Mereniuk","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.lfs.2022.120380_bb0050","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/ijbs.42197","article-title":"Histone acetyltransferase (HAT) P300\/CBP inhibitors induce synthetic lethality in PTEN-deficient colorectal cancer cells through destabilizing AKT","volume":"16","author":"Liu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200801099","article-title":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents","volume":"183","author":"Degtyarev","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2022.120380_bb0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jhet.5570170814","article-title":"Synthesis of heterocycles. Part II. New routes to acetylthiadiazolines and alkylazothiazoles","volume":"17","author":"Eweiss","year":"1980","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.lfs.2022.120380_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1246\/bcsj.48.365","article-title":"Synthesis and rearrangement of ethyl aryloxy-glyoxalate arylhydrazones","volume":"48","author":"Shawali","year":"1975","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.lfs.2022.120380_bb0070","series-title":"Synthesis and reactions of phenylcarbamoylarylhydrazidic chlorides","first-page":"2517","volume":"27(12)","author":"Shawali","year":"1971"},{"key":"10.1016\/j.lfs.2022.120380_bb0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3987\/COM-87-4381","article-title":"Chemistry of C-heteroarylhydrazidoyl halides. Synthesis and reactions of N-(P-nitrophenyl)-C-(2-thienyl)-formohydrazidoyl halides","volume":"27","author":"Hassaneen","year":"1988","journal-title":"Heterocycles"},{"issue":"2","key":"10.1016\/j.lfs.2022.120380_bb0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jep.2012.09.032","article-title":"Induction of quinone oxidoreductase 1 enzyme by Rhazya stricta through Nrf2-dependent mechanism","volume":"144","author":"El Gendy","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0944-7113(98)80059-7","article-title":"In vitro and in vivo activities of Melia azedarach L. aqueous leaf extracts on murine lymphocytes","volume":"5","author":"Courreges","year":"1998","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2022.120380_bb0090","article-title":"Gold nanorods are selective cytotoxic agents","author":"El Gendy","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.lfs.2022.120380_bb0095","first-page":"45","article-title":"Growth delay effect of combined interstitial hyperthermia and brachytherapy in a rat solid tumor model","volume":"9","author":"Papadopoulos","year":"1989","journal-title":"Anticancer Res."},{"issue":"18","key":"10.1016\/j.lfs.2022.120380_bb0100","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1073\/pnas.0400099101","article-title":"Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents","volume":"101","author":"Rasouli-Nia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.120380_bb0105","first-page":"1584","article-title":"Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients","volume":"14","author":"Mozaffarieh","year":"2008","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.lfs.2022.120380_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The comet assay for DNA damage and repair: principles, applications, and limitations","volume":"26","author":"Collins","year":"2004","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120380_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"issue":"41","key":"10.1016\/j.lfs.2022.120380_bb0120","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1021\/bi030127b","article-title":"Spectroscopic studies of DNA and ATP binding to human polynucleotide kinase: evidence for a ternary complex","volume":"42","author":"Mani","year":"2003","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.lfs.2022.120380_bb0125","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1158\/0008-5472.CAN-09-1805","article-title":"Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase\/phosphatase","volume":"69","author":"Freschauf","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120380_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/01926230600867743","article-title":"Normal structure, function, and histology of the spleen","volume":"34","author":"Cesta","year":"2006","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0140","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1038\/s41598-018-23669-9","article-title":"Subcutaneous Ehrlich ascites carcinoma mice model for studying cancer-induced cardiomyopathy","volume":"8","author":"Mishra","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120380_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1440-1681.13071","article-title":"Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma","volume":"46","author":"Alkreathy","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120380_bb0150","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026104","article-title":"The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression","volume":"6","author":"Chen","year":"2016","journal-title":"Cold Spring Harb.Perspect.Med."},{"key":"10.1016\/j.lfs.2022.120380_bb0155","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014479","article-title":"The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis","volume":"296","author":"Mashimo","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2022.120380_bb0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41419-020-03210-5","article-title":"WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer","volume":"11","author":"Ertay","year":"2020","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.lfs.2022.120380_bb0165","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1158\/0008-5472.CAN-04-1767","article-title":"PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells","volume":"64","author":"Lee","year":"2004","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.lfs.2022.120380_bb0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj3440427","article-title":"Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation","volume":"344","author":"Nave","year":"1999","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharep.2013.06.006","article-title":"Antitumoral effect of a selective rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice","volume":"66","author":"Isler","year":"2014","journal-title":"Pharmacol.Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120380_bb0180","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1142\/S0192415X07005314","article-title":"In vivo antitumoral effect of Plantago major L. extract on Balb\/C mouse with Ehrlich ascites tumor","volume":"35","author":"Ozaslan","year":"2007","journal-title":"<sb:contribution><sb:title>Am. J.<\/sb:title> <\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>Chin. Med.<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"issue":"13","key":"10.1016\/j.lfs.2022.120380_bb0185","first-page":"2375","article-title":"Ehrlich ascites carcinoma","volume":"10","author":"Ozaslan","year":"2011","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.lfs.2022.120380_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/495305","article-title":"DNA damage and inhibition of akt pathway in mcf-7 cells and Ehrlich tumor in mice treated with 1,4-naphthoquinones in combination with ascorbate","volume":"2015","author":"Ourique","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.lfs.2022.120380_bb0195","article-title":"Anti-cancer properties of theaflavins","volume":"26","author":"O'Neill","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.lfs.2022.120380_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010144","article-title":"Mechanistic pathways and molecular targets of plant-derived anticancer ent-kaurane diterpenes","volume":"10","author":"Sarwar","year":"2020","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.lfs.2022.120380_bb0205","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2174\/1871520619666190306123658","article-title":"Biological activity, apoptotic induction and cell cycle arrest of new hydrazonoyl halides derivatives","volume":"19","author":"Mohamed","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120380_bb0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tibs.2011.01.006","article-title":"Tidying up loose ends: the role of polynucleotide kinase\/phosphatase in DNA strand break repair","volume":"36","author":"Weinfeld","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"17","key":"10.1016\/j.lfs.2022.120380_bb0215","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-09-2990","article-title":"PI(3)king apart PTEN's role in cancer","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120380_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2004.01.017","article-title":"Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma","volume":"210","author":"Khor","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2022.120380_bb0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120380_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:56:19Z","timestamp":1758401779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":44,"alternative-id":["S0024320522000807"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120380","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrazonoyl chlorides possess promising antitumor properties","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120380"}}